| Trial ID: | L0489 |
| Source ID: | ChiCTR1800017879
|
| Associated Drug: |
Vitamin D
|
| Title: |
Vitamin D through Banlancing of Gut Microbiota to Improve Non-alcoholic Steatohepatitis (NASH)
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non-alcoholic steatohepatitis
|
| Interventions: |
Intervention group:Medical treatment+Viamin D: 600,000 IP for the first treatment,and additional 300,000 IU treatment in the following month for total 4 treatments.;control group:Medical treatment;
|
| Outcome Measures: |
Liver function biochemical index;B Ultrasound liver;glucose and lipids profiles;gut microbiota;Immunology: T lymphocyte subsets;
|
| Sponsor/Collaborators: |
Public Health and Clinical Center of Chengdu
|
| Gender: |
All
|
| Age: |
nannan
|
| Phases: |
Other
|
| Enrollment: |
Intervention group:42;control group:42;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Randomized parallel controlled trial
|
| Start Date: |
20/08/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
27 August 2018
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=25264
|
